Cancer News and Research

Latest Cancer News and Research

Monash University research offers new hope to people with heart attacks

Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects.

11 Mar 2014

OBiS releases preliminary results from 2014 global physician breast cancer survey

OBiS releases preliminary results from its 2014 global physician breast cancer survey. The survey included treatment data and insights from over 50 countries and 500 treating physicians.

11 Mar 2014

USMD Holdings' primary care clinics receive reaccreditation from PCMH Program

USMD Holdings, Inc., a physician-led integrated healthcare system, announced today that all 26 of its primary care clinics have received reaccreditation for an additional three-year term from the Patient-Centered Medical Home (PCMH) Program, a recognition program that is part of the National Committee for Quality Assurance.

11 Mar 2014

Aetna, Atlantic ACO announce new accountable care agreement

Aetna and Atlantic Accountable Care Organization, a partner of Atlantic Health System, today announced a new accountable care agreement that will improve the coordination and delivery of patient care. Atlantic ACO will deliver a better patient experience for more than 28,000 Aetna members in Morris, Sussex, Union, Somerset, Warren and Passaic counties.

11 Mar 2014

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.

11 Mar 2014

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

11 Mar 2014

New version of QuadraMed Computerized Patient Record now available

QuadraMed Corporation is pleased to announce the General Availability of the next major version of its enterprise EHR solution, QuadraMed Computerized Patient Record. QCPR version 6.0 provides key capabilities and improvements that help organizations provide high-quality and efficient care; meet pressing Canadian, as well as U.S. governmental and industry regulations; and deliver better patient safety, patient engagement, data security, and privacy while being fully interoperable.

11 Mar 2014

Exosome Diagnostics closes Series B financing round with the raising of $27 million

Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.

11 Mar 2014

First Edition: March 11, 2014

Today's headlines include reports that the Centers for Medicare & Medicaid Services is stepping back from proposed changes to the Medicare drug program.

11 Mar 2014

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

11 Mar 2014

SCCA experts develop helpful tool to simplify colon cancer prevention, screening guidelines

Colon cancer will take more than 50,000 American lives in 2014 making it the second leading cause of cancer-related deaths, according to the American Cancer Society.

11 Mar 2014

UTSA College of Sciences faculty members honored at 2014 Annual Meeting of AAAS

UTSA College of Sciences faculty members Andrew Tsin, Garry Cole and Donald Kurtz were honored recently at the 2014 Annual Meeting of the American Association for the Advancement of Science (AAAS) in Chicago.

11 Mar 2014

Researchers investigate stickiness of leukaemia cells and its link to drug resistance

Researchers in Manchester have investigated the stickiness of leukaemia cells, and whether this is linked to drug resistance.

11 Mar 2014

Highlights: Mental health problems in Va.; Kan. autism coverage mandate; device-makers' new disclosures

After the Virginia Tech massacre in 2007, Virginia lawmakers injected tens of millions of dollars into the state's mental-health system, including local mental-health agencies that are the first stop for people in crisis.

11 Mar 2014

Thirteen graduate students to receive 2014 Harold M. Weintraub Graduate Student Award

Thirteen graduate students from institutes throughout North America have been chosen to receive the 2014 Harold M. Weintraub Graduate Student Award sponsored by the Basic Sciences Division of Fred Hutchinson Cancer Research Center.

11 Mar 2014

Chronic smokers have altered emotional reactions when exposed to negative, positive images of tobacco

What if the use of a product influenced your perception of it, making you even more susceptible to its positive aspects and altering your understanding of its drawbacks? This is precisely what happens with cigarettes in chronic smokers, according to a recent study by the Institut universitaire en santé mentale de Montréal and University of Montreal.

11 Mar 2014

Sugars attached to proteins can be used to detect ovarian cancer, say researchers

The hunt is on to find biomarkers that detect cancer, but it's a challenging process. Early successes often are followed by heartbreaking failures. But now, researchers at UC Davis have verified that glycans (sugars attached to proteins) can be used to detect ovarian cancer. The study was published online in the journal Cancer Epidemiology, Biomarkers & Prevention.

11 Mar 2014

Glycoprofiling test could halve number of false-positives in diagnosis of ovarian cancer

The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Now, chemists at the University of Copenhagen working with clinical researchers at University College London have developed a method able to halve the number of false-positives.

11 Mar 2014

Scientists invent a pair of high-tech glasses that help surgeons visualize cancer cells during surgeries

A team of scientists at Washington University School of Medicine in St. Louis (WUSTL) and the University of Arizona (UA) in Tucson led by Samuel Achilefu have created a pair of high-tech glasses that help surgeons visualize cancer cells during surgeries, which glow blue when viewed through the glasses.

11 Mar 2014

Scientists discover new protein that drive metastasis of cancer cells

An international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body.

11 Mar 2014

Cancer News and Research

Latest Cancer News and Research

Monash University research offers new hope to people with heart attacks

OBiS releases preliminary results from 2014 global physician breast cancer survey

USMD Holdings' primary care clinics receive reaccreditation from PCMH Program

Aetna, Atlantic ACO announce new accountable care agreement

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

New version of QuadraMed Computerized Patient Record now available

Exosome Diagnostics closes Series B financing round with the raising of $27 million

First Edition: March 11, 2014

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

SCCA experts develop helpful tool to simplify colon cancer prevention, screening guidelines

UTSA College of Sciences faculty members honored at 2014 Annual Meeting of AAAS

Researchers investigate stickiness of leukaemia cells and its link to drug resistance

Highlights: Mental health problems in Va.; Kan. autism coverage mandate; device-makers' new disclosures

Thirteen graduate students to receive 2014 Harold M. Weintraub Graduate Student Award

Chronic smokers have altered emotional reactions when exposed to negative, positive images of tobacco

Sugars attached to proteins can be used to detect ovarian cancer, say researchers

Glycoprofiling test could halve number of false-positives in diagnosis of ovarian cancer

Scientists invent a pair of high-tech glasses that help surgeons visualize cancer cells during surgeries

Scientists discover new protein that drive metastasis of cancer cells

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in